This educational review provides detailed insight into the pathophysiology, prevalence and disease burden, and diagnosis and management, of familial hypercholesterolaemia (FH). As heterozygous FH (HeFH) is the predominant form of FH, it is the primary focus of the review. Throughout the review, HeFH is generally referred to simply as FH, unless specified otherwise.
Independent Commentary by: Gerald F. Watts and David .R. Sullivan
Please login below to download this issue (PDF)